Protein quality control and metabolism: bidirectional control in the heart
- PMID:25651176
- PMCID: PMC4317573
- DOI: 10.1016/j.cmet.2015.01.016
Protein quality control and metabolism: bidirectional control in the heart
Abstract
The prevalence of heart disease, especially heart failure, continues to increase, and cardiovascular disease remains the leading cause of death worldwide. As cardiomyocytes are essentially irreplaceable, protein quality control is pivotal to cellular homeostasis and, ultimately, cardiac performance. Three evolutionarily conserved mechanisms-autophagy, the unfolded protein response, and the ubiquitin-proteasome system-act in concert to degrade misfolded proteins and eliminate defective organelles. Recent advances have revealed that these mechanisms are intimately associated with cellular metabolism. Going forward, comprehensive understanding of the role of protein quality control mechanisms in cardiac pathology will require integration of metabolic pathways and metabolic control.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
We declare no conflicts of interest.
Figures



Similar articles
- The critical roles of protein quality control systems in the pathogenesis of heart failure.Maejima Y.Maejima Y.J Cardiol. 2020 Mar;75(3):219-227. doi: 10.1016/j.jjcc.2019.09.019. Epub 2019 Nov 4.J Cardiol. 2020.PMID:31699567Review.
- The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.Patterson C, Ike C, Willis PW 4th, Stouffer GA, Willis MS.Patterson C, et al.Circulation. 2007 Mar 20;115(11):1456-63. doi: 10.1161/CIRCULATIONAHA.106.649863.Circulation. 2007.PMID:17372187Review.
- Recent progress in research on molecular mechanisms of autophagy in the heart.Maejima Y, Chen Y, Isobe M, Gustafsson ÅB, Kitsis RN, Sadoshima J.Maejima Y, et al.Am J Physiol Heart Circ Physiol. 2015 Feb 15;308(4):H259-68. doi: 10.1152/ajpheart.00711.2014. Epub 2014 Nov 14.Am J Physiol Heart Circ Physiol. 2015.PMID:25398984Free PMC article.Review.
- Cardiac ubiquitin ligases: Their role in cardiac metabolism, autophagy, cardioprotection and therapeutic potential.Parry TL, Willis MS.Parry TL, et al.Biochim Biophys Acta. 2016 Dec;1862(12):2259-2269. doi: 10.1016/j.bbadis.2016.07.002. Epub 2016 Jul 13.Biochim Biophys Acta. 2016.PMID:27421947Free PMC article.Review.
- Into the heart: the emerging role of the ubiquitin-proteasome system.Willis MS, Patterson C.Willis MS, et al.J Mol Cell Cardiol. 2006 Oct;41(4):567-79. doi: 10.1016/j.yjmcc.2006.07.015. Epub 2006 Sep 1.J Mol Cell Cardiol. 2006.PMID:16949602Review.
Cited by
- Unfolded Protein Response as a Therapeutic Target in Cardiovascular Disease.Zhang G, Wang X, Gillette TG, Deng Y, Wang ZV.Zhang G, et al.Curr Top Med Chem. 2019;19(21):1902-1917. doi: 10.2174/1568026619666190521093049.Curr Top Med Chem. 2019.PMID:31109279Free PMC article.Review.
- Exercise training decreases the load and changes the content of circulating SDS-resistant protein aggregates in patients with heart failure with reduced ejection fraction.Gouveia M, Schmidt C, Basilio PG, Aveiro SS, Domingues P, Xia K, Colón W, Vitorino R, Ferreira R, Santos M, Vieira SI, Ribeiro F.Gouveia M, et al.Mol Cell Biochem. 2024 Oct;479(10):2711-2722. doi: 10.1007/s11010-023-04884-z. Epub 2023 Oct 30.Mol Cell Biochem. 2024.PMID:37902886Free PMC article.
- Poly (ADP-ribose) polymerases 16 triggers pathological cardiac hypertrophy via activating IRE1α-sXBP1-GATA4 pathway.Su H, Xu J, Su Z, Xiao C, Wang J, Zhong W, Meng C, Yang D, Zhu Y.Su H, et al.Cell Mol Life Sci. 2023 May 23;80(6):161. doi: 10.1007/s00018-023-04805-9.Cell Mol Life Sci. 2023.PMID:37219631Free PMC article.
- Increasing the Unneddylated Cullin1 Portion Rescues thecsn Phenotypes by Stabilizing Adaptor Modules To Drive SCF Assembly.Liu Q, Zhou Y, Tang R, Wang X, Hu Q, Wang Y, He Q.Liu Q, et al.Mol Cell Biol. 2017 Nov 13;37(23):e00109-17. doi: 10.1128/MCB.00109-17. Print 2017 Dec 1.Mol Cell Biol. 2017.PMID:28923850Free PMC article.
- Ovarian Tumor Domain-Containing 7B Attenuates Pathological Cardiac Hypertrophy by Inhibiting Ubiquitination and Degradation of Krüppel-Like Factor 4.Du BB, Zhang JL, Kong LY, Shi HT, Zhang DH, Wang X, Yang CL, Li PC, Yao R, Liang C, Wu LM, Huang Z.Du BB, et al.J Am Heart Assoc. 2023 Dec 19;12(24):e029745. doi: 10.1161/JAHA.123.029745. Epub 2023 Dec 12.J Am Heart Assoc. 2023.PMID:38084712Free PMC article.
References
- Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol. 1994;267:H742–750. - PubMed
- Antos CL, McKinsey TA, Dreitz M, Hollingsworth LM, Zhang CL, Schreiber K, Rindt H, Gorczynski RJ, Olson EN. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. The Journal of biological chemistry. 2003;278:28930–28937. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials